Annals of Epidemiology
Volume 20, Issue 2 , Pages 159-167 , February 2010

Evaluating Respondent-Driven Sampling in a Major Metropolitan Area: Comparing Injection Drug Users in the 2005 Seattle Area National HIV Behavioral Surveillance System Survey with Participants in the RAVEN and Kiwi Studies

  • Richard D. Burt, PhD

      Affiliations

    • Public Health – Seattle & King County, Seattle, WA
    • Corresponding Author InformationAddress correspondence to: Richard D. Burt, PhD, Public Health – Seattle & King County, 400 Yesler Way, Seattle WA 98104. Tel.: (206) 296-4580; Fax: (206) 205-5281.
    • ,
  • Holly Hagan, PhD

      Affiliations

    • Public Health – Seattle & King County, Seattle, WA
    • ,
  • Keith Sabin, PhD

      Affiliations

    • Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Hanne Thiede, DVM, MPH

      Affiliations

    • Public Health – Seattle & King County, Seattle, WA

Received 3 April 2009 ,Accepted 18 October 2009.

References 

  1. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 61. Atlanta, GA: U.S. Department of Health and Human Services; 2006;
  2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Vol. 18. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports. 2008. Accessed December 2009.
  3. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl. 2):S67–S72
  4. Semaan S, Lauby J, Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Rev. 2002;4:213–223
  5. Heckathorn DD. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems. 1997;44:174–199
  6. Heckathorn DD. Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations. Social Problems. 2002;29:11–34
  7. Salganik M, Heckathorn DD. Sampling and estimation in hidden populations using respondent-driven sampling. Sociological Methodology. 2004;34:193–239
  8. Johnston LG, Malekinjad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using Respondent-Driven Sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008;12:S131–S141
  9. Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using Respondent-Driven Sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12:S105–S130
  10. Johnston LG, Sabin K, Mai TH, Pham TH. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: reaching the unseen sex worker. J Urban Health. 2007;83:i16–i28
  11. Johnston LG, Khanam R, Reza M, Khan SI, Banu S, Alam MS, et al. The effectiveness of respondent driven sampling for recruiting males who have sex with males in Dhaka, Bangladesh. AIDS Behav. 2008;12:294–304
  12. Kendall C, Kerr LR, Gondim RC, Werneck GL, Macena RH, Pontes MK, et al. An empirical comparison of respondent-driven sampling, time location sampling, and snowball sampling for behavioral surveillance in men who have sex with men, Fortaleza, Brazil. AIDS Behav. 2008;12:S97–S104
  13. Ma X, Zhang Q, He X, Sun W, Yue H, Chen S, et al. Trends in prevalence of HIV, syphilis, hepatitis C, hepatitis B, and sexual risk behavior among men who have sex with men. Results of 3 consecutive respondent-driven sampling surveys in Beijing, 2004 through 2006. J Acquir Immune Defic Syndr. 2007;45:581–587
  14. McKnight C, Des JD, Bramson H, Tower L, Abdul-Quader AS, Nemeth C, et al. Respondent-driven sampling in a study of drug users in New York City: notes from the field. J Urban Health. 2006;83:i54–i59
  15. Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnston LF, et al. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health. 2007;83:i39–i82
  16. Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005;95:387–402
  17. Ramirez-Valles J, Garcia D, Campbell RT, Diaz RM, Heckathorn DD. HIV infection, sexual risk behavior, and substance use among Latino gay and bisexual men and transgender persons. Am J Public Health. 2008;98:1036–1042
  18. Robinson WT, Risser JMH, McGoy S, Becker AB, Rehman H, Jefferson M, et al. Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. J Urban Health. 2007;87:i29–i37
  19. Simic M, Johnston LF, Platt L, Baros S, Andjelkovic V, Novotny T, et al. Exploring barriers to ‘respondent driven sampling’ in sex worker and drug injecting sex worker populations in eastern Europe. J Urban Health. 2007;83:i6–i15
  20. Stormer A, Tum W, Guli L, Harxhi A, Bodanovskaia Z, Yakovleva A, et al. An analysis of respondent driven sampling with injection drug users (IDU) in Albania and the Russian Federation. J Urban Health. 2007;83:i73–i82
  21. Wang J, Carlson RG, Falck RS, Siegal HA, Rahman A, Li L. Respondent-driven sampling to recruit MDMA users: a methodological assessment. Drug Alcohol Depend. 2005;78:147–157
  22. Wang J, Falck RS, Li L, Rahman A, Carlson RG. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues. Addict Behav. 2007;32:924–937
  23. Wattana W, van Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, Bannatham R, et al. Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend. 2007;90:228–233Epub 2007 May 15
  24. Wejnert C, Heckathorn D. Web-based network sampling; efficiency and efficacy of respondent-driven sampling for online research. Soc Methods Res. 2008;37:105–134
  25. Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein RS, et al. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl. 1):48–55
  26. Abdul-Quader AS, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Sabin K, et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health. 2006;83:459–476
  27. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149:203–213
  28. Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377–400
  29. Thiede H, Romero M, Bordelon K, Hagan H, Murrill CS. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. J Urban Health. 2001;78:264–278
  30. RDSAT. Version 5.6.0. Available at: http://www.respondentdrivensampling.org 2008. Accessed December 2009.
  31. NETDRAW. Available at: http://www.analytictech.com/downloadnd.htm. 2008. Accessed December 2009.
  32. RDS Incorporated. RDSAT_56_Manual.pdf. Available at: http://www.respondentdrivensampling.org. 2007. Accessed December 2009.
  33. Reisner SL, Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Predictors of identifying as a barebacker among high-risk New England HIV seronegative men who have sex with men. J Urban Health. 2009;86:250–262
  34. Uuskula A, Kals M, Rajaleid K, Abel K, Talu A, Ruutel K, et al. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf). 2008;30:119–125
  35. Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83:i98–112
  36. Goel S, Salganik MJ. Respondent-driven sampling as Markov chain Monte Carlo. Consultation on the analysis of data collected through RDS. Atlanta: Centers for Disease Control and Prevention; 2008;
  37. Statistical Package for the Social Sciences. Version 14. Chicago: 2004.
  38. Epistat. Tracy Gustafson. Round Rock (TX): 2008.
  39. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse: Advance Report. U.S. Department of Health and Human Services; National Institutes of Health. Available at: http://www.drugabuse.gov/PDF/CEWG/AdvReport106.pdf. 2006. Accessed December 2009.
  40. Burt RD, Thiede H. Results from the National HIV/AIDS Survey of injection drug users in the Seattle area, 2005. Washington State/Seattle-King County HIV/AIDS Epidemiology Report, First half, 2007. Available at: http://www.kingcounty.gov/healthservices/health/communicable/hiv/epi/reports.aspx 2007. Accessed December 2009.
  41. Hall HI, Song R, Gerstle JE, Lee LM. Assessing the completeness of reporting of human immunodeficiency virus diagnoses in 2002-2003: capture-recapture methods. Am J Epidemiol. 2006;164:391–397
  42. Banta-Green C, Jackson TR, Freng S, Hanrahan M, Albert DH, Harruff R, et al. Recent drug abuse trends in the Seattle-King County Area. Community Epidemiology Work Group, June 2007. Available at: http://www.kingcounty.gov/healthservices/health/drugs/SubstanceAbuse.aspx. 2007. Accessed December 2009.
  43. Roberts DL, Ball J. The DAWN Report: Amphetamine and methamphetamine emergency department visits, 1995-2002. Rockville, Md: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2004;
  44. U.S. Census. American Factfinder. Available at: http://factfinder.census.gov/servlet/DatasetMainPageServlet?_program=ACS&_submenuId=datasets_1&_lang=en&_ts=2007. Accessed December 2009.

 Current affiliations: New York University, New York City (H.H.), and the World Health Organization, Geneva, Switzerland (K.S.).

PII: S1047-2797(09)00339-1

doi: 10.1016/j.annepidem.2009.10.002

Annals of Epidemiology
Volume 20, Issue 2 , Pages 159-167 , February 2010

Article Tools

* Image Usage & Resolution